---
figid: PMC7974027__gr7
figtitle: Schematic depicting possiblem echanisms governing the pro-tumorigenesis
  effect of NET and miR181a targets in the PGRMC1/EGFR–PI3K/Akt/mTOR signaling pathway
  in breastepithelialMCF10Acells
organisms:
- Homo sapiens
- Mus musculus
organisms_ner:
- Mus musculus
- Homo sapiens
- Drosophila melanogaster
- Danio rerio
pmcid: PMC7974027
filename: gr7.jpg
figlink: pmc/articles/PMC7974027/figure/fig0007/
number: F7
caption: Schematic depicting possiblem echanisms governing the pro-tumorigenesis effect
  of NET and miR181a targets in the PGRMC1/EGFR–PI3K/Akt/mTOR signaling pathway in
  breastepithelialMCF10Acells. Akt, proteinkinaseB(PKB); BCL2, B-celllymphoma2; CASP-7,
  caspase7; CASP-9, caspase9; EGFR, epidermal growth factor receptor; ER, estrogen
  receptor; mTOR, mechanistic target of rapamycin; NET, norethister one; PCNA, proliferating
  cell nuclear antigen; PGRMC1, progesterone receptor membrane component 1; PI3K,
  phosphoinositide-3-kinase; PIP2, phosphatidylinositol (4,5)-bisphosphate; PIP3,
  phosphatidylinositol (3,4,5)-trisphosphate; PR, progesteronereceptor; PTEN, phosphatase
  and tensinhomolog.
papertitle: MicroRNA-181a suppresses norethisterone-promoted tumorigenesis of breast
  epithelial MCF10A cells through the PGRMC1/EGFR–PI3K/Akt/mTOR signaling pathway.
reftext: Guiju Cai, et al. Transl Oncol. 2021 Jun;14(6):101068.
year: '2021'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9497342
figid_alias: PMC7974027__F7
figtype: Figure
redirect_from: /figures/PMC7974027__F7
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7974027__gr7.html
  '@type': Dataset
  description: Schematic depicting possiblem echanisms governing the pro-tumorigenesis
    effect of NET and miR181a targets in the PGRMC1/EGFR–PI3K/Akt/mTOR signaling pathway
    in breastepithelialMCF10Acells. Akt, proteinkinaseB(PKB); BCL2, B-celllymphoma2;
    CASP-7, caspase7; CASP-9, caspase9; EGFR, epidermal growth factor receptor; ER,
    estrogen receptor; mTOR, mechanistic target of rapamycin; NET, norethister one;
    PCNA, proliferating cell nuclear antigen; PGRMC1, progesterone receptor membrane
    component 1; PI3K, phosphoinositide-3-kinase; PIP2, phosphatidylinositol (4,5)-bisphosphate;
    PIP3, phosphatidylinositol (3,4,5)-trisphosphate; PR, progesteronereceptor; PTEN,
    phosphatase and tensinhomolog.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Elk3
  - Slc6a2
  - Ephb1
  - Egfr
  - Pgrmc1
  - Pten
  - Mir181a-2
  - pr
  - Pik3r1
  - Atp1b1
  - Mtor
  - Pcna
  - Ccnd1
  - Bcl2
  - Casp7
  - Casp9
  - ELK3
  - EPHB1
  - SLC6A2
  - EGFR
  - PGRMC1
  - PTEN
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - MTOR
  - PCNA
  - CCND1
  - BCL2
  - CASP7
  - CASP9
  - net
  - Neto
  - NetA
  - NetB
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - ATPsynbetaL
  - ATPsynbeta
  - ATPsynF
  - Tor
  - Debcl
  - egfra
  - pgrmc1
  - ptenb
  - mtor
  - pcna
  - ccnd1
  - bcl2a
  - casp7
  - casp9
  - Progestin
---
